
    
      150 index patients (children or young adult) will be prospectively recruited over three years
      according to eligibility criteria. Relatives will be also recruited.

      Clinical, brain MRI-MRA and genetic testing (COL4A1 mutation screening) will be conducted for
      each included patient or asymptomatic relatives. 13 French investigating centres will be
      participating to the study.
    
  